BMS-986253 is a monoclonal antibody biosimilar expressed in CHO cells, targeting IL-8(Granulocyte chemotactic protein 1, Monocyte-derived neutrophil-activating peptide, IL-8(1-77), IL-8(9-77), Monocyte-derived neutrophil chemotactic factor, IL-8(7-77), (Ser-IL-8)72, GCP/IL-8 protein V, MONAP, C-X-C motif chemokine 8, GCP/IL-8 protein I, Neutrophil-ac), HuMax-IL8 (BMS-986253) is a novel fully human monoclonal antibody that binds to and inhibits IL-8, a chemokine that promotes immune escape and tumor progression.
Biosimilars
Human
Monoclonal
Human
IL-8(Granulocyte chemotactic protein 1, Monocyte-derived neutrophil-activating peptide, IL-8(1-77), IL-8(9-77), Monocyte-derived neutrophil chemotactic factor, IL-8(7-77), (Ser-IL-8)72, GCP/IL-8 protein V, MONAP, C-X-C motif chemokine 8, GCP/IL-8 protein I, Neutrophil-ac)
Human
IgG1
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más